Tibet Aim Pharm., Inc. (002826) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Tibet Aim Pharm., Inc.

Why is Tibet Aim Pharm., Inc. ?

Poor long term growth as Net Sales has grown by an annual rate of 0.65% and Operating profit at 24.70% over the last 5 years

With a growth in Net Profit of 1934.12%, the company declared Very Positive results in Sep 25

The company has declared positive results in Jan 70 after 2 consecutive negative quarters
ROCE(HY) Highest at 11.19%
PRE-TAX PROFIT(Q) Highest at CNY 53.05 MM
RAW MATERIAL COST(Y) Fallen by -24.38% (YoY)

With ROE of 5.93%, it has a expensive valuation with a 4.87 Price to Book Value

Over the past year, while the stock has generated a return of 64.51%, its profits have fallen by -25.7%
At the current price, the company has a high dividend yield of 0.4

Market Beating performance in long term as well as near term

Along with generating 64.51% returns in the last 1 year, the stock has outperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Tibet Aim Pharm., Inc. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Tibet Aim Pharm., Inc. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Tibet Aim Pharm., Inc.

74.8%

2.13

54.59%

China Shanghai Composite

13.33%

0.90

14.74%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

0.65%

EBIT Growth (5y)

24.70%

EBIT to Interest (avg)

24.78

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.60

Sales to Capital Employed (avg)

0.87

Tax Ratio

21.41%

Dividend Payout Ratio

40.00%

Pledged Shares

Institutional Holding

ROCE (avg)

6.70%

ROE (avg)

6.15%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

4.87

EV to EBIT

71.13

EV to EBITDA

48.85

EV to Capital Employed

11.08

EV to Sales

5.41

PEG Ratio

Dividend Yield

0.35%

ROCE (Latest)

15.58%

ROE (Latest)

5.93%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

26What is working for the Company

ROCE(HY)

Highest at 11.19%

PRE-TAX PROFIT(Q)

Highest at CNY 53.05 MM

RAW MATERIAL COST(Y)

Fallen by -24.38% (YoY

CASH AND EQV(HY)

Highest at CNY 1,093.63 MM

DEBT-EQUITY RATIO (HY)

Lowest at -68.68 %

NET SALES(Q)

Highest at CNY 177.54 MM

NET PROFIT(Q)

Highest at CNY 44.21 MM

EPS(Q)

Highest at CNY 0.24

-11What is not working for the Company

INTEREST(HY)

At CNY 0.64 MM has Grown at 205.26%

INTEREST COVERAGE RATIO(Q)

Lowest at 6,015.2

INVENTORY TURNOVER RATIO(HY)

Lowest at 3.28 times

Here's what is working for Tibet Aim Pharm., Inc.

Pre-Tax Profit

At CNY 53.05 MM has Grown at 1,103.96%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 44.21 MM has Grown at 1,934.12%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CNY MM)

Pre-Tax Profit

Highest at CNY 53.05 MM and Grown

In each period in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Sales

Highest at CNY 177.54 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Net Profit

Highest at CNY 44.21 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.24

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Cash and Eqv

Highest at CNY 1,093.63 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Debt-Equity Ratio

Lowest at -68.68 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost

Fallen by -24.38% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Tibet Aim Pharm., Inc.

Interest

At CNY 0.64 MM has Grown at 205.26%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest Coverage Ratio

Lowest at 6,015.2

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Inventory Turnover Ratio

Lowest at 3.28 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio